The blockbuster weight loss drug sold as Ozempic and Wegovy [has, on 21 March, gone] generic in countries that are home to 40 percent of the world’s population, significantly lowering the price of a costly medicine that had been largely unaffordable to nearly all but the wealthiest people. On Saturday, Novo Nordisk, the company that until now has had a monopoly on selling the drug, will lose patent protection in several of the world’s most populous countries. The first generic versions are expected to arrive in India as soon as this weekend. In the coming months, the generics are also expected to become available in China, Canada, Brazil, Turkey and South Africa.

    • paraphrand@lemmy.world
      link
      fedilink
      English
      arrow-up
      11
      ·
      2 months ago

      Exactly. And these drugs were originally diabetes medications. And they don’t cure diabetes.

    • quickenparalysespunk@lemmy.dbzer0.com
      link
      fedilink
      English
      arrow-up
      2
      arrow-down
      4
      ·
      1 month ago

      sorry but some people do say it’s inefficient and unfair. insulin is not free (not in all countries at least) and it’s extra effort and task management which is forced on people, some of them just because they were born with diabetes and never had a choice.

      it’s like a tax for being born a certain way.

      • 🍉 DrRedOctopus 🐙🍉@lemmy.world
        link
        fedilink
        English
        arrow-up
        1
        ·
        1 month ago

        insulin is practically free to make, is about a couple $ per month without subsidies.

        If you pay more than that it is a literal scam and people belong in jail.

        • SaveTheTuaHawk@lemmy.ca
          link
          fedilink
          English
          arrow-up
          1
          ·
          1 month ago

          insulin is practically free to make, is about a couple $ per month without subsidies.

          No drug is inexpensive to make at GMP level.